Retatrutide 60mg

Retatrutide (LY3437943, often shortened to Reta) is a synthetic peptide studied as an agonist at three hormone receptors: GLP-1, GIP and glucagon. An agonist activates a receptor. These receptors participate in appetite signalling, blood-glucose regulation and energy metabolism.

Published research examines how activating all three pathways affects metabolic responses. This describes the compound studied in the literature, not a demonstrated outcome from this research vial.

Sources: Retatrutide receptor study

Reta and Reta peptide are shorthand for Retatrutide. LY3437943 is its research development code. R3TA and “ratatouille peptide” appear as informal online nicknames. “Reda peptide” also appears in informal discussion, but is not a verified chemical synonym. These labels are not separate compounds or reliable identifiers.

When comparing listings, look for Retatrutide and the labelled vial amount. Pillar supplies Retatrutide for Research Use Only.

Retatrutide is studied at GLP-1, GIP and glucagon receptors. Tirzepatide is studied at GIP and GLP-1 receptors. They are different compounds, not interchangeable names or strengths. Compare the required compound identity first, then vial amount and price.

Compare Retatrutide strengths · Tirzepatide listing

No. This listing supplies a vial of lyophilised Retatrutide research material. It is not a pen, cartridge, ready-made solution or pharmacy product. The price covers the selected vial strength; it does not describe a finished product for personal use.

One vial labelled 60mg of Retatrutide, supplied as lyophilised (freeze-dried) powder. The mg value is the labelled amount in the vial, not a solution concentration.

For Research Use Only, for in vitro laboratory work. Not for human or animal consumption.

The catalogue lists these amounts:

• 10mg: A$144.99 per vial
• 15mg: A$179.99 per vial
• 20mg: A$209.99 per vial
• 30mg: A$269.99 per vial
• 40mg: A$329.99 per vial
• 60mg: A$449.99 per vial

Select a strength above to see its availability. A larger vial changes the amount supplied, not the compound’s identity.

Pillar Research lists Retatrutide 60mg on this product page for Research Use Only. This strength is available to preorder. Dispatch date to be confirmed. No dispatch or delivery date has been confirmed.

Orders are placed online. For in-stock items, select the quantity and add to cart; for preorders, check the dispatch estimate before ordering.

Retatrutide 60mg is listed at A$449.99 per vial, in Australian dollars. The price is for this strength, not every variant.

Any applicable offer and shipping charges are shown in the order total before payment. Check the availability shown above before ordering.

In-stock orders are dispatched from Australian stock with tracking. Delivery timing depends on dispatch, destination and the carrier. A preorder dispatch estimate is separate from transit time.

Check the selected strength’s availability and the shipping options at checkout. Current delivery estimates and charges are explained in the shipping policy.

Australian shipping information

Follow the storage conditions and expiry on the supplied label and any accompanying handling documentation. Keep the original container and batch identification.

If a temperature range or shelf life is missing, request it before use. A general product-page answer cannot establish stability after a laboratory preparation is made.